Sean R. Porazinski
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Matrix Stiffness Directs Stemness Signatures in Breast Cancer.
Journal: Advanced healthcare materials
Published: March 02, 2026
Integration of Whole-Genome Sequencing Analysis with Unique Patient-Derived Models Reveals Clinically Relevant Drug Targets in TFCP2 Fusion-Defined Rhabdomyosarcoma.
Journal: Molecular cancer therapeutics
Published: December 24, 2024
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response.
Journal: Science advances
Published: July 03, 2024
SPHINX-Based Combination Therapy as a Potential Novel Treatment Strategy for Acute Myeloid Leukaemia.
Journal: British journal of biomedical science
Published: November 09, 2022
Oral Squamous Cell Carcinoma in Young Patients Show Higher Rates of EGFR Amplification: Implications for Novel Personalized Therapy.
Journal: Frontiers in oncology
Published: July 31, 2021
Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1.
Journal: Nature chemical biology
Published: October 14, 2020
TLR2 activation promotes tumour growth and associates with patient survival and chemotherapy response in pancreatic ductal adenocarcinoma.
Journal: Oncogene
Published: September 02, 2020
EPHA2-dependent outcompetition of KRASG12D mutant cells by wild-type neighbors in the adult pancreas.
Journal: Current biology : CB
Published: August 24, 2020
WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1.
Journal: Biochimica et biophysica acta. Gene regulatory mechanisms
Published: May 29, 2020
Rho-ROCK Signaling in Normal Physiology and as a Key Player in Shaping the Tumor Microenvironment.
Journal: Advances in experimental medicine and biology
Published: February 08, 2020
Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer.
Journal: British journal of cancer
Published: August 02, 2019
Last Updated: 09/26/2026